Evidence map›Paper›PMID 38021184›Full record

ArticleGerms2022

The key role of the ophthalmologist in diagnosing botulism: two case reports.

Larisa Cujba, Ovidiu Samoila, Silvina Ilut, Vitalie Vacaras, Cristina Stan

Open access · greenAbstract readCase Reports
In one paragraph

Article in Germs, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Larisa CujbaMD, PhD Student, Medical Doctoral School, University of Oradea, 1 Universiăţii Street, 410087 Oradea, Romania.
Ovidiu SamoilaMD, PhD, Department of Ophthalmology, "Iuliu Haţieganu" University of Medicine and Pharmacy, Clinicilor Street no 3-5, 400006, Cluj-Napoca, Romania.
Silvina IlutMD, PhD, Department 10 Neurosciences, "Iuliu Haţieganu" University of Medicine and Pharmacy, 400012, Cluj-Napoca, Romania.
Vitalie VacarasMD, PhD, Department of Clinical Neurosciences, "Iuliu Haţieganu" University of Medicine and Pharmacy, 400012, Cluj-Napoca, Romania.
Cristina StanMD, PhD, Department of Ophthalmology, "Iuliu Haţieganu" University of Medicine and Pharmacy, Clinicilor Street no 3-5, 400006, Cluj-Napoca, Romania.
Iuliu Hațieganu University of Medicine and Pharmacy · ROUniversity of Oradea · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Botulinum toxin, the strongest known neurotoxin, is the cause of a rare fatal neuroparalytic disease characterized by the so-called "four Ds": diplopia, dysarthria, dysphagia, dry mouth. If left untreated, botulism may cause paralysis of the respiratory muscles, impairing the respiratory function which can ultimately lead to death. Case report: We describe the cases of two patients who presented, two years apart, with similar ocular symptoms such as blurred vision due to accommodation palsy, diplopia, accompanied by xerostomia and swallowing disorders, which were further confirmed as botulism. Both cases had a similar clinical presentation of the intoxication and a positive response to treatment with botulinum antitoxin, while only the first case had a laboratory confirmation of the disease. Conclusions: The key to diagnose botulism correctly is based on high clinical suspicion and requires a medical multidisciplinary approach and urgent specific treatment. Ophthalmology specialists must be aware of the disease, especially in cases in which ophthalmic manifestation appear at the onset.

Indexed as

accommodation palsyBotulismdiplopiaeyefoodbornexerostomia

Identifiers

PMID38021184
PMCPMC10660219
OpenAlexW4388817103

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.